1Romero S, Martmez A, Hernandez L, et al. Light's criteria revisited: consistency and comparison with new proposed alternative criteria for separating pleural transudates from exudates[J]. Respiration, 2000, 67 (1):18-23. 被引量:1
4Yokoe T. lino Y, Morishita Y. Trends of IL-6 and IL- 8 levels in patients with recurrent breast cancer; preliminary report[J]. Breast Cancer, 2000,7 ( 3 ) : 187. 被引量:1
2Jin HY, Lee KS, Jin SM,et al. Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion[J]. Respir Med. 2004,98 (2) : 115 - 122. 被引量:1
3Hada M. Report of two cases with pleural effusion and asci- tes that responded dramatically to the combination of thalido-mide, celeeoxib, irinotecan, and CDDP infused in thoracic and abdominal cavities[J]. Gan To Kagaku Ryoho. 2004,31 (4):613-617. 被引量:1
4Hamed Ea, EI-Noweihi AM, Mohamed AZ. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions[J]. Respirology, 2004, 9 (1):81 -86. 被引量:1
5Yeh HH, Lai WW, Chen HH, etal. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion [J]. Oncogene, 2006,25(31) :4300 - 4309. 被引量:1
6Kaya A, Poyraz B, Celik G, et al. Vascular endothelial growth factor in benign and malignant pleural effusions[J]. Arch Bronconeumol,2005, 41 (7) :376 - 379. 被引量:1
7Kalomenidis I, Kollintza A, Sigala I, et al. Angiopoietin-2 levels are elevated in exudative pleural effusions[J]. Chest, 2006, 129(5):1259- 1266. 被引量:1
8Matsumori Y, Yano S, Goto H,et al. ZD6474, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, inhibits growth of experimental lung metastasis and production of malignant pleural effusions in a non-small cell lung cancer model[J]. Oncol Res, 2006, 16( 1 ) : 15 - 26. 被引量:1
9Shamshiev A, Gober HJ, Donda A,et al. Presentation of the same glyeolipid by different CD1 molecules[J]. J Exp Med, 2002, 195(8):1013 -1019. 被引量:1
10Stenger S, Niazi KR, Modli RL. Down-regulation of CD1 on antigen-pressenting cells by infection with Myeobaeterium tuberculosis[J]. J lmmunol, 1998, 161(7):3582-3588. 被引量:1
6Light RW,MaegregorM I,Luchsinger PC, et al. Pleural effu- sions: the diagnostic of transudates and exudates[J]. Ann Intern Med, 1972, 77(3):507-513. 被引量:1
7Sun YC, Wang GF, Hu H, et al. Investigation on the diag- nostic state of pleural effusions in part of hospital of Beijing [J]. Chinese Journal of Tuberculosis and Respiratory Disea- ses, 2001, 24(2):124- 125. 被引量:1
8Rahman NM,AIi NJ,Brown G,et al. British Thoracic Society Pleural Disease Guideline Group. Local anaesthetic thoracos- copyz British Thoracic Society Pleural Disease Guideline [J]. Thorax,2010,65(2): 54-60. 被引量:1
9Wang CY, Hsiao YC, Jerng .IS, et al. Diagnostic value of proealcitonin in pleural effusions[J]. Eur J Clin Microbiol In- fect Dis,2011,30: 313-318. 被引量:1
10Wang CY, Hsiao YC, Jerng JS, et al. Diagnostic value of procalcitonin in pleural effusions[J]. Eur J Clin Microbiol In- Ject Dis,2011,30: 313-318. 被引量:1